Lisa Tannock, MD | Saha Cardiovascular Research Center

Lisa Tannock, MD

Connect
About
Education
Publications

Primary Contact: Cassandra A Rogers

859-323-7404

Charles T. Wethington Bldg 900 South Limestone St, Lexington, KY 40536-0200

Biosketch

Position(s):

Senior Associate Dean for Faculty Affairs and Development

Professor

Acting Chief, Division of Endocrinology & Metabolism Medicine

Affiliation(s):

Internal Medicine

Cardiovascular Research Center

ODEI

Saha Aortic Center

Other Affiliation(s):

Internal Medicine - Endocrinology

CVRC - Core Faculty

Nutritional Sciences Graduate Faculty

Equity Advisory Council

Bio / Education:

University of Toronto, Toronto, Canada	MD	06/1994	Medicine
University of Toronto, Toronto, Canada	Residency	06/1997	Internal Medicine
University of Washington, Seattle, WA	Fellowship	06/2000	Endocrinology

Selected Publications:

1. Tannock LR, Little PJ, Wight TN, Chait A: Arterial smooth muscle cell proteoglycans synthesized in the presence of glucosamine demonstrate reduced LDL binding. J Lipid Res 43:149-157, 2002. PMID:11792734.
2. Tannock LR, Little PJ, Tsoi C, Barrett PHR, Wight TN, Chait A: Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans. Diabetologia. 47:837-843, 2004. PMID:15071727.
3. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest. 114:659-668, 2004. PMID:15343384 :PMC514580
4. Tannock LR, O’Brien KD, Knopp RH, Retzlaff B, Fish B, Wener MH, Kahn SE, Chait A: Cholesterol feeding increases CRP and SAA levels in lean, insulin sensitive subjects. Circulation 111:3058-3062, 2005. PMID:15939816.
5. Tannock LR, Kirk EA, King VL, LeBoeuf R, Wight TN, Chait A: Glucosamine Supplementation Accelerates Early but not Late Atherosclerosis in LDL Receptor Deficient Mice. J Nutr 136:2856-2861, 2006. PMID:17056813.

PubMed Publications:

Ji, A.; Wang, X.; Noffsinger, VP ; Jennings, D ; De Beer, MC ; Beer, FC ; Tannock, LR ; Webb, NR "Serum amyloid A is not incorporated into HDL during HDL biogenesis." Journal of lipid research 61, 3 (2020): 328-337. [PubMed Link] | [ Full text ]
Chalfant, JM ; Howatt, DA ; Tannock, LR ; Daugherty, A.; Pendergast, JS "Circadian disruption with constant light exposure exacerbates atherosclerosis in male ApolipoproteinE-deficient mice." Scientific reports 10, 1 (2020): 9920. [PubMed Link] | [ Full text ]
Newman, CB ; Blaha, MJ ; Boord, JB ; Cariou, B ; Chait, A.; Fein, HG ; Ginsberg, HN ; Goldberg, IJ ; Murad, MH ; Subramanian, S.; Tannock, LR "Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline." The Journal of clinical endocrinology and metabolism 105, 12 (2020): [PubMed Link] | [ Full text ]
Shridas, P.; Tannock, LR "Role of serum amyloid A in atherosclerosis." Current opinion in lipidology 30, 4 (2019): 320-325. [PubMed Link] | [ Full text ]
Thompson, JC ; Wilson, PG ; Shridas, P.; Ji, A.; Beer, M.; Beer, FC ; Webb, NR ; Tannock, LR "Serum amyloid A3 is pro-atherogenic." Atherosclerosis 268, (2018): 32-35. [PubMed Link] | [ Full text ]
Tannock, LR ; De Beer, MC ; Ji, A.; Shridas, P.; Noffsinger, VP ; Hartigh, L.; Chait, A.; Beer, FC ; Webb, NR "Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein." Journal of lipid research 59, 2 (2018): 339-347. [PubMed Link] | [ Full text ]
Wilson, PG ; Thompson, JC ; Shridas, P.; McNamara, PJ ; De Beer, MC ; Beer, FC ; Webb, NR ; Tannock, LR "Serum Amyloid A Is an Exchangeable Apolipoprotein." Arteriosclerosis, thrombosis, and vascular biology 38, 8 (2018): 1890-1900. [PubMed Link] | [ Full text ]
Hager, MR ; Narla, AD ; Tannock, LR "Dyslipidemia in patients with chronic kidney disease." Reviews in endocrine & metabolic disorders 18, 1 (2017): 29-40. [PubMed Link] | [ Full text ]
Grandoch, M.; Kohlmorgen, C.; Melchior-Becker, A.; Feldmann, K.; Homann, S.; Muller, J.; Kiene, LS ; Zeng-Brouwers, J.; Schmitz, F.; Nagy, N.; Polzin, A.; Gowert, NS ; Elvers, M.; Skroblin, P.; Yin, X.; Mayr, M.; Schaefer, L.; Tannock, LR ; Fischer, JW "Loss of Biglycan Enhances Thrombin Generation in Apolipoprotein E-Deficient Mice: Implications for Inflammation and Atherosclerosis." Arteriosclerosis, thrombosis, and vascular biology 36, 5 (2016): e41-50. [PubMed Link] | [ Full text ]
Tannock, L.; Feingold, KR ; Anawalt, B ; Boyce, A ; Chrousos, G.; de Herder, WW ; Dhatariya, K ; Dungan, K.; Grossman, A.; Hershman, JM ; Hofland, J ; Kalra, S ; Kaltsas, G ; Koch, C.; Kopp, P ; Korbonits, M.; Kovacs, CS ; Kuohung, W ; Laferrère, B ; McGee, EA ; McLachlan, R.; Morley, JE ; New, M.; Purnell, J.; Sahay, R ; Singer, F.; Stratakis, CA ; Trence, DL ; Wilson, DP "Dyslipidemia in Chronic Kidney Disease" (2000): [PubMed Link] |
Bhatt, D.; Tannock, L.; Feingold, KR ; Anawalt, B ; Boyce, A ; Chrousos, G.; de Herder, WW ; Dhatariya, K ; Dungan, K.; Grossman, A.; Hershman, JM ; Hofland, J ; Kalra, S ; Kaltsas, G ; Koch, C.; Kopp, P ; Korbonits, M.; Kovacs, CS ; Kuohung, W ; Laferrère, B ; McGee, EA ; McLachlan, R.; Morley, JE ; New, M.; Purnell, J.; Sahay, R ; Singer, F.; Stratakis, CA ; Trence, DL ; Wilson, DP "Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis" (2000): [PubMed Link] |